Paloma Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,768
| Closed | -$319K | – | 613 |
|
|
2024
Q3 | $319K | Sell |
4,768
-1,189
| -20% | -$79.5K | 0.01% | 517 |
|
|
2024
Q2 | $707K | Buy |
5,957
+2,863
| +93% | +$340K | 0.02% | 303 |
|
|
2024
Q1 | $330K | Buy |
+3,094
| New | +$330K | 0.02% | 272 |
|
|
2023
Q4 | – | Sell |
-77
| Closed | -$7.95K | – | 365 |
|
|
2023
Q3 | $7.95K | Buy |
+77
| New | +$7.95K | ﹤0.01% | 188 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 368 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 347 |
|
|
2022
Q4 | – | Sell |
-4,024
| Closed | -$476K | – | 440 |
|
|
2022
Q3 | $476K | Buy |
4,024
+2,376
| +144% | +$281K | 0.02% | 142 |
|
|
2022
Q2 | $235K | Sell |
1,648
-3,892
| -70% | -$555K | 0.01% | 521 |
|
|
2022
Q1 | $954K | Buy |
5,540
+1,087
| +24% | +$187K | 0.03% | 275 |
|
|
2021
Q4 | $1.13M | Buy |
+4,453
| New | +$1.13M | 0.02% | 486 |
|
|
2021
Q3 | – | Sell |
-45
| Closed | -$11K | – | 1350 |
|
|
2021
Q2 | $11K | Buy |
+45
| New | +$11K | ﹤0.01% | 1468 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1978 |
|
|
2020
Q4 | – | Sell |
-3,000
| Closed | -$212K | – | 1763 |
|
|
2020
Q3 | $212K | Sell |
3,000
-57,072
| -95% | -$4.03M | 0.01% | 1551 |
|
|
2020
Q2 | $3.86M | Buy |
+60,072
| New | +$3.86M | 0.07% | 346 |
|
|
2020
Q1 | – | Sell |
-17,374
| Closed | -$340K | – | 1534 |
|
|
2019
Q4 | $340K | Buy |
+17,374
| New | +$340K | 0.01% | 1382 |
|